 "investment, investment bankers, brokers, investors, company, firms, board, directors, CEOs, management, funding, tech, economy, gdp, aif, alternative investment fund, capital, startups, tech, savings, money, cash, shares, funds, equity")
LifeCell International, India's leading stem cell bank and reproductive genetic testing services provider, announced on Tuesday a successful fundraise of Rs 225 crore from OrbiMed Asia Partners IV, a leading healthcare investment firm. As part of this round, the existing founders of LifeCell will also participate by investing Rs 30 crore.
“Having transformed the approach in cord blood stem cell preservation through its innovative community banking model, LifeCell has over the last few years undertaken several growth initiatives in genetic and genomic testing for maternal and newborn health, and innovative placental tissue-based products for wound healing,” said Mayur Abhaya, Managing Director,
